Management Of Metabolic Syndrom and Gout Artritis 63 Years Old Man At Puskesmas Kedaton with Family Medicine Approach


  • Siti Raqiya Rasyid University of Lampung
  • Fitria Saftarina



family medicine, gout arthritis, holistic management, metabolic syndrome, family medicine, gout arthritis, holistic management, metabolic syndrome


Metabolic syndrome (MS) is a complex metabolic disorder caused by increased obesity. The main components of BC are obesity, insulin resistance, dyslipidemia, and hypertension. Metabolic syndrome is a collection of risk factors for cardiovascular disease. Another metabolic disease is gout arthritis. This study aims to identify risk factors and clinical problems in the patient. They are applying the principles of family doctor services according to patient problems and carrying out holistic and comprehensive management, including a patient-centered and family approach based on Evidence-Based Medicine. Mr. L's 63-year-old patient was diagnosed with Metabolic Syndrome and Gout Arthritis. Patients have aspects of internal risk in the form of a lack of knowledge of the patient the disease suffered and the proper lifestyle by the disease and curative treatment patterns; external risk aspects in patients is a lack of knowledge and family support in treatment. Furthermore, holistic management of patients and families is carried out. The diagnosis and management of these patients have been made holistically, patient-centered, family approach, following national guidelines, and based on evidence-based medicine. The knowledge and behavior in patient and family changes occur after patient-centered and family-approach interventions.

Author Biography

Fitria Saftarina




Widjaya A. 2004. Obesitas dan Sindrom Metabolik.Jurnal Cardiology. 2(4):1–16.2.

Supari F. 2005. Metabolic syndrome. Jurnal Kedokteran Indonesia. 55(10):618–21.3.

Mokdad AH, Marks JS, Stroup DF. 2006. Actual Causes of Death in the United States. Journal American Medical Association.291(20):1238–45.4.

Ford ES, Giles WH, Dietz WH, 2002. Prevalence of the MetabolicSyndrome Among US Adults. Finding from the Third National Health and Nutrition Examination Survey. Journal American Medical Association. 287(20):356–59.5.

Cameron AJ, Shaw JE, Zimmet PZ. 2004. The Metabolic Syndrome Prevalence in Worldwide Populations. Journal of Endocrinol Metabolic. 33(2):351–75.

Riskesdas. 2018. Hasil utama RISKESDAS 2018. Jakarta: Badan Penelitian dan Pengembangan Kesehatan.

ADA (American Diabetes Association), 2019. Classification and Diagnosis of Diabetes : Standards of Medical Care in Diabetes.Diabetes Care, 42 (1), 13-28.

Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S, editor. 2006. Buku ajar ilmu penyakit dalam. Edisi Ke-4. Jakarta: Depertemen Ilmu Penyakit Dalam FK UI.

Mayasari dan Sitepu. Penatalaksanaan holistik pada pasien hipertensi dan obesitas derajat II dengan riwayat stroke melalui pendekatan kedokteran keluarga. J Medula Unila. 2015; 9 (4): 676-84.

PERKENI. Konsensus Pengendalian dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia. Jakarta: PB PERKENI; 2015.

PRI. Konsensus Pengendalian dan Pencegahan Gout Artritis di Indonesia. Jakarta: PB PRI; 2014

Kim HS, Kim DIABETES MELLITUS, Cha BS, Park TS, Kim KA, Kim DL, dkk. Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea. JDI



How to Cite

Siti Raqiya Rasyid, & Saftarina, F. (2023). Management Of Metabolic Syndrom and Gout Artritis 63 Years Old Man At Puskesmas Kedaton with Family Medicine Approach. Medical Profession Journal of Lampung, 13(4), 639-648.